Compare · AMRO vs SNN

AMRO vs SNN

Side-by-side comparison of Amaero Inc. (AMRO) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • AMRO operates in Industrials, while SNN operates in Health Care - the two are in different parts of the market.
  • SNN is the larger of the two at $13.04B, about 100.4x AMRO ($129.9M).
  • SNN has hit the wire 4 times in the past 4 weeks while AMRO has been quiet.
  • SNN has more recent analyst coverage (25 ratings vs 0 for AMRO).
MetricAMROSNN
Company
Amaero Inc.
Smith & Nephew SNATS Inc.
Price
-
-
Market cap
$129.9M
$13.04B
1M return
-
+15.58%
1Y return
-
-6.23%
Industry
Industrial Specialties
Industrial Specialties
Exchange
NASDAQ
NYSE
IPO
2026
News (4w)
0
4
Recent ratings
0
25
AMRO

Amaero Inc.

Amaero Inc. is a leading U.S.-based producer of high-value refractory and titanium alloy spherical metal powders for additive manufacturing ('AM') and advanced manufacturing, and a pioneer in Powder Metallurgy Hot Isostatic Pressing ('PM-HIP') manufacturing of large near-net-shape components. With manufacturing and corporate headquarters in Tennessee, we occupy a strategically critical position at the intersection of U.S. national security priorities, including the rebuilding of a more resilient and scalable defense industrial base and the reshoring of sovereign manufacturing and supply chains.

SNN

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.